OHE 0.00% $1.10 orion health group limited

Ann: GENERAL: OHE: Orion Health Q4 FY15 Business Update

  1. lightbulb Created with Sketch. 2
    • Release Date: 28/04/15 09:24
    • Summary: GENERAL: OHE: Orion Health Q4 FY15 Business Update
    • Price Sensitive: No
    • Download Document  5.54KB
    					OHE
    28/04/2015 09:24
    GENERAL
    PRICE SENSITIVE
    REL: 0924 HRS Orion Health Group Limited
    
    GENERAL: OHE: Orion Health Q4 FY15 Business Update
    
    Q4 FY15 BUSINESS UPDATE ANNOUNCEMENT: Orion Health Group Limited (OHE)
    28 April 2015, Auckland
    
    Orion Health Group Limited (Orion Health), a global leader in healthcare
    software and services, will have a business update conference call for
    investors at 11am NZST on 28 April 2015.
    
    This business update will cover:
    
    1. FY15 Unaudited Operating Revenue
    Orion Health today announces its unaudited operating revenue for the year
    ended 31 March 2015 (FY15). Unaudited FY15 operating revenue was $164 million
    up 7% from $153 million in FY14.
    
    All regions experienced growth for the year except for North America. As
    expected and previously noted, revenue in this region was constrained by the
    execution of our strategy to transition from perpetual licences to
    subscription revenue and a delay in contract closures.
    
    Full details will be provided in the annual results announcement on 26 May
    2015.
    
    2. March 2015 Annualised Recurring Revenue
    The transition to increased levels of recurring revenue is a key driver of
    our business model.
    
    As at 31 March 2015 our Annualised Recurring Revenue was $63 million compared
    to $44 million at 31 March 2014, an increase of 43%.
    
    3. Q4 Cash Flow
    Orion Health today released a cash flow report for the quarter ending 31
    March 2015 (Q4 FY15) in accordance with ASX listing rules. As at 31 March
    2015 Orion Health had cash and short-term deposits of $95 million. Net
    operating cash flow in Q4 FY15 was $0.8 million. Cash receipts from customers
    in Q4 were $53 million, an improvement from $30 million in Q3 FY15.
    Significant quarterly variances in cash receipts are typical for Orion Health
    due to lumpiness of contract revenues and seasonal factors and quarterly
    fluctuations are expected to be ongoing.
    
    4. Significant Software Release at HIMSS 2015
    In April 2015, Orion Health publicly launched and demonstrated its Amadeus
    Big Data Engine together with a range of new products and new versions of its
    software solutions at the largest global healthcare IT conference (HIMSS) in
    Chicago.
    Of particular note were:
    a) Open Platform - The evolution of our platform outlined in the IPO
    documentation, the Open Platform (powered by our Amadeus Big Data Engine)
    integrates large volumes of payer (claims), provider, and other health data
    and is attracting a great deal of attention from the payer market. Our
    research indicates that this is one of the first population health big data
    solutions in the market, and the first with a major implementation.
    b) Clinical Workflow Suite, part of Orion Health Coordinate - One of the
    first vendors to release a comprehensive clinical workflow suite, with
    several support workflow types, including healthcare pathways and referrals.
    
    c) Amadeus Analytics - An evolution of our Analytics offering outlined in the
    IPO documentation, Amadeus Analytics integrates in real time with our Amadeus
    Big Data Engine.
    d) Allegro - A new application providing secure messaging and chat between
    patients, doctors and other healthcare providers.
    These and other Orion Health products generated substantial interest at the
    HIMSS conference.  Analyst and industry feedback has been that the Amadeus
    Big Data Engine appeared to be unique and industry leading.
    
    5. North American Performance
    Q4 was a challenging period for Orion Health's North American Operating
    Revenue, as we continued the transition from a perpetual licence model to a
    subscription model. There is strong interest in Orion Health's Healthier
    Populations solutions from North American Payer (insurance) and healthcare
    provider organisations. In Q4 we executed a contract with a prestigious
    Integrated Clinical Network to deploy our Healthier Populations solution and
    we are now seeing market procurement activity returning to historical levels,
    consistent with our expectations. Specific opportunities with Payers continue
    to progress and we anticipate additional contractual closures in FY16.
    Specific detail of material engagements will be released as the contracts are
    finalised.
    
    There is emerging opportunity created by the recently announced Centers for
    Medicare and Medicaid Services (CMS) Chronic Care Management (CCM)
    Reimbursement programme, which Orion Health is pursuing in collaboration with
    Qualcomm.
    
    6. Rest of World Performance
    Orion Health's Asia Pacific and Europe & Middle East regions have continued
    to perform well in the past quarter. In particular, the United Kingdom
    business has enjoyed a strong run of contracting activity with National
    Health Service Trusts and Clinical Commissioning Groups.
    
    7. Business Improvement Initiatives
    Orion Health has commenced a number of ongoing initiatives to increase
    service capacity and reduce overhead costs. One of the key initiatives is
    investment in Implementation Services and Managed Services execution
    capability, which includes global standardisation of the company's approach
    to its Software as a Service (SaaS) delivery model.
    
    Conference Call Details:
    Toll Free Number: 0800 452 782
    If calling from outside New Zealand: +64 9 887 6907
    Conference ID: 2995 6622
    
    Please note that it may take five to ten minutes for the moderator to take
    your details and place you into the call.
    
    Webcast Details:
    http://www.openbriefing.com/OB/1779.aspx
    Audience members may arrive 15 minutes prior to the event start time.
    
    Please note that you will not be able to ask questions via the webcast
    
    Contact:
    Bridget Snelling
    Investor Relations Manager
    [email protected]
    End CA:00263588 For:OHE    Type:GENERAL    Time:2015-04-28 09:24:29
    				
 
watchlist Created with Sketch. Add OHE (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.